Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW – Washington State University Teams Up With Pot Company to Study Medical Marijuana

On November 6, one of the universities which was granted federal land by the Morrill Acts of 1862 and 1890, Washington State University, announced that it would be partnering with Biopharmaceutical Research Company (BRC) to advance the research on medical marijuana and its impacts. BRC is a pharmaceutical company registered with the DEA.

Washington State University issued a press release saying that it partnered with the pharmaceutical company to launch an innovative study to evaluate marijuana and speed up the pace of marijuana research. The partnership will give the WSU scientists access to marijuana for research purposes while adhering to the federal regulations on cannabis.

The partnership will also enable WSU researchers to use BRC analytical services and knowledge to study the effect of marijuana on the physical and mental health of the consumers. It will also explore the impact of marijuana policies on public health and safety.

The Chair of Washington State University (WSU) Collaborative for Cannabis Policy, Research, and Outreach (CCPRO), Dr. Michael McDonnell, said that compared to other drugs, very little is known about the benefits and risks of marijuana. And for the researchers to obtain the pot they need to research its health effects on animals and humans, they must overcome several hurdles. Dr. McDonnell further said that WSU’s partnership with BRC would solve the problem of acquiring weed since BRC would provide them with marijuana for research purposes through federally compliant processes.

For the past 50-plus years, researchers have been allowed to source for marijuana for clinical trials from the University of Mississippi farm, which is federally approved and operated by the National Institute of Drug Abuse.

This is outright monopolization that leads to limited access to cannabis by the researchers, which then slows the progression of marijuana studies for years. In 2019, the federal government announced its plans to increase the number of producers cultivating marijuana for scientific research.

The collaboration between WSU and BRC is expected to help in addressing the importance of easy access to quality marijuana for research purposes; however, neither of the two entities is allowed to grow cannabis.

The Biopharmaceutical Research Company (BRC) CEO George Hodgin said that working with a reputable research institution such as WSU guarantees that they will be working with the best researchers in discovering the benefits of the pot products. It will also make sure that BRC is taking care of its responsibilities of ensuring public safety. Hodgin further said that the products have shown a great deal of potential by treating a variety of health conditions such as PTSD and chronic pain, yet the lack of federally-approved research in the U.S. is highly evident.

BRC applied for a cultivation permit in 2016, and if granted, the company would be in position to grow and produce marijuana and marijuana-derived products for research.

Analysts say this research is a welcome activity in the eyes of marijuana companies like Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) and Dama Financial since the research findings will provide further proof of the therapeutic value of marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Set to Profit from FDA’s MRTP Pathway Announcement

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator with technology that has demonstrated its ability to enhance the oral delivery of nicotine, is positioned to benefit from the FDA’s recent announcement that it had authorized the marketing of eight smokeless tobacco products through the modified-risk, tobacco-product (“MRTP”) pathway (http://cnw.fm/PaC87). An article discussing the company reads, “The FDA approval of the ‘modified risk’ claims was made after reviewing scientific evidence submitted by the manufacturer of the products. The approvals, which are product specific and expire after five years, do not mean the products come with no health risks. Nicotine-based products are addictive and may, according to some studies, induce the onset of cardiovascular, respiratory and gastrointestinal disorders. . . . The patented DehydraTECH(TM) drug-delivery platform mitigates a serious limitation to nicotine ingestion. The human GI system struggles to process nicotine in the forms in which it is presently offered, one reason why there are currently no edible, nicotine, manufactured products available, although some natural foods — eggplant, green pepper, potato, tomato — do contain nicotine. However, DehydraTECH employs a delivery mechanism that improves the bioabsorption and bioavailability of many ingestible substances, as well as their taste and smell, by using lipophilic agents. Application of the technology extends beyond nicotine to nonpsychoactive cannabinoids, vitamins and nonsteroidal anti-inflammatory drugs (NSAIDs).”

To view the full article, visit http://cnw.fm/W5qBi

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a global innovator in drug-delivery platforms. Its patented DehydraTECH drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bioabsorption, reduces time of onset and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Dama Financial to Offer Free Banking Access to Eligible Cannabis-Related Businesses

Dama Financial, a leading provider of access to electronic banking and payment solutions, this morning announced its plan to offer cannabis-related businesses (“CRBs”) that qualify under its Social Equity Program (“SEP”) free access to banking. The company has designed the financial infrastructure specifically for CRBs that are impeded by the shortcomings related to cash-based operations. Businesses that qualify for application to their respective state or county’s SEP are now authorized to apply to Dama’s SEP and obtain free access to banking.

To view the full press release, visit http://cnw.fm/XvK1L

About Dama Financial

Dama Financial provides transparent, sustainable banking and payment solutions to cash-intensive industries. Using innovative technology, data and artificial intelligence, Dama Financial exceeds the compliance and regulatory requirements for servicing high-risk businesses. Dama Financial’s industry experts are enabling another unbanked category to achieve their potential by removing the barriers that exclude them from accessing fundamental financial solutions. For more information, visit the company’s website at www.DamaFinancial.com.

NOTE TO INVESTORS: The latest news and updates relating to Dama Financial are available in the company’s newsroom at http://cnw.fm/Dama

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – LiveWire Ergogenics Inc. (LVVV) Completes Official Launch of 7X Pure Verification System and Website

LiveWire Ergogenics (OTC: LVVV) today announced the launch of the first 7X Pure Compliance and Dosage Verification System for cannabis products and website www.7XPure.org. LiveWire Ergogenics, in cooperation with Basso Botanicals, launched the 7X Pure system, which provides third party verification of material of origin, potency, purity, dosage, labeling and more and, after approval, verifies each product with a digital identity and clearly-identifiable chain of custody. “We have been working closely with Basso for some time to fine tune and perfect our 7X Pure Testing and Verification system,” Livewire Ergogenics CEO Bill Hodson said in the news release. “We are pleased that Basso’s Peppermint Tincture will be the first product being marketed nationwide after having passed through the rigorous 7X Pure verification system. We are looking forward to making the 7X Pure system available to manufacturers in the entire industry, creating the opportunity to increase transparency and accountability throughout the supply chain with the goal to improve product quality and reliability and increase consumer confidence in their product purchase decisions.”

To view the full press release, visit http://cnw.fm/A7zaD

About LiveWire Ergogenics Inc.

LiveWire Ergogenics, Inc. (LVVV) specializes in identifying and monetizing current and future trends in the human and veterinary health and wellness industry. The Company is focused on acquiring, managing and licensing specialized “closed loop” turnkey cannabis real estate locations of fully compliant and permitted turnkey facilities to produce cannabis-based products and services in California and the state-wide distribution of these products. This includes verification of zero pesticide products for quality brands via its “7X Pure” Cannabis Verification System, the development, licensing and distribution of legal and high-quality cannabinoid-based products and services and the creation of the high-quality “Estrella Weedery” brand. LiveWire Ergogenics does not produce, sell or distribute products that are in violation of the United States Controlled Substance Act. For more information, please visit: LiveWireErgogenics.com.

NOTE TO INVESTORS: The latest news and updates relating to LVVV are available in the company’s newsroom at http://cnw.fm/LVVV

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

HempNewsBreaks – SinglePoint, Inc. (SING) Provides 2019 Recap, Outlook for 2020

SinglePoint (OTCQB: SING), a technology and investment company, this morning provided a recap of 2019 and outlook for 2020. The company exceeded $1,000,000 in revenue for Q3, making it its largest third quarter in company history. Moving forward, SING sees substantial growth in two major markets, hemp and solar, and is focused on growing within these market segments throughout the fourth quarter and into 2020. The company is launching its nicotine and tobacco free 1606 Original Hemp cigarettes at MJBIZCON taking place at the Las Vegas Convention Center December 11-13, 2019. SinglePoint expects the sale of 1606 to be a key contributor to overall company growth in 2020. “We have an exceptional strategic plan in making SinglePoint one of the biggest publicly traded companies in the smokable hemp space. We believe we offer investors and our current shareholders tremendous value given our leadership position in several explosive markets including ecommerce, Hemp and Solar. As SinglePoint continues to grow revenue and profit we continue to strive for meeting the qualifications to apply for a listed exchange,” SinglePoint CEO Greg Lambrecht stated in the news release.

To view the full press release, visit http://cnw.fm/Y0LVo

About SinglePoint Inc.

SinglePoint invests in and acquires brands and companies that will benefit from injection of growth capital and the sales and marketing expertise of SinglePoint. The company portfolio currently includes solar renewables, Hemp and distribution tobacco products. SinglePoint is working to grow to a multi-national brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade, Inc. (SGMD) Advances Toward Nasdaq Exchange Uplisting

Sugarmade (OTCQB: SGMD), a major supplier to the hydroponic cultivation and hemp sectors, today provided an update as it moves toward an uplisting of shares onto a major U.S. exchange following news that Sugarmade’s direct competitor, GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen”), announced on Monday, November 25, that its shares have been approved for listing on the Nasdaq Capital Market (“NASDAQ”). According to the update, company management believes that, following its strategic move to acquire BZRTH, Inc., as well as another acquisition to be announced in the near future, that Sugarmade is very similar to GrowGen, on an overall, consolidated basis, in terms of market segment, scale of operations and financial performance metrics. As a result, Sugarmade believes GrowGen’s move onto the Nasdaq is a very promising signal as the company prepares to uplist its own shares. “The approval of GrowGen shares for the move up onto the Nasdaq market is a great sign for Sugarmade as we prepare to make a similar move,” Sugarmade CEO Jimmy Chan said in the news release. “It’s a positive signal about the hydroponics market and about our overall strategy. It’s time for institutional investors to get heavily involved in the pick-and-shovel ancillary markets surrounding the hemp and hemp-related boom. GrowGen has done a great job, and we are hot on their tail right now, and plan to surpass them in the race to number one in the hydroponics space.”

To view the full press release, visit http://cnw.fm/c9uoE

About Sugarmade, Inc.

Sugarmade, Inc. (OTCQB: SGMD) is a product and branding marketing company investing in operations and technologies with disruptive potential. The Company is becoming a leading supplier to the growing hemp industry and is benefitting from the growth of the hydroponic marketplace. The Company is in the process of acquiring several leading hydroponic and agricultural supply companies that are currently producing in excess of $70 million in annual revenues. Sugarmade is also an investor in fast growing Hempistry, Inc., a Kentucky-based cultivator of industrial hemp, and operates Carryoutsupplies.com a leader provider to the quick service restaurant industry. For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Bolsters its Strategic Advisory Board with Kevin Durant’s Thirty Five Ventures

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the expansion of its strategic advisory board to add Thirty Five Ventures, the business owned by NBA star Kevin Durant and sports business executive Rich Kleiman. According to the update, Thirty Five Ventures will collaborate with Canopy Rivers as it continues to pursue its global growth strategy and strengthen its global portfolio of leading cannabis companies. Canopy Rivers will also look to co-invest with Thirty Five Ventures on cannabis-related deals, leveraging the group’s expertise in brand development and marketing. “We’re thrilled to have Thirty Five Ventures join the Canopy Rivers team,” Narbé Alexandrian, president and CEO of Canopy Rivers, said in the news release. “Kevin Durant and Rich Kleiman have built an incredible brand worldwide, investing in and growing some of the cannabis and tech industry’s hottest companies. We’re excited to combine our venture capital knowledge and cannabis domain expertise, and we believe that this partnership will drive success for our portfolio as we continue to grow it in the years ahead.”

To view the full press release, visit http://cnw.fm/pw4Lf

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – VPR Brands LP (VPRB) Provides Update on Monetization, Enforcement of Electronic Cigarette Utility Patent

VPR Brands (OTCQB: VPRB), a market leader specializing in vaporizers and accessories for essential oils, cannabis concentrates and extracts (“CBD”), as well as electronic cigarettes containing nicotine, on Monday provided an update regarding the monetization and enforcement of its U.S. utility patent for electronic cigarettes. The company’s patented technology is one of the earliest filed electronic cigarette patents and includes two broad, independent claims encompassing products with an electric airflow sensor, including a sensor comprised of a diaphragm microphone. VPR Brands has begun identifying more than 50 infringing companies, based on sales volume, and has started notifying the companies of their infringement. Per the update, VPRB recently hired intellectual property (“IP”) law firm SRIPLAW to advise the company on monetization strategy and manage and execute the process. The company’s monetization strategy includes licensing and or manufacturing contracts with infringing brand owners. “Having personally been in the vape industry for the past 10 years and witnessing the evolution of e-Cig and vapor technology, it is befitting that our company owns this US utility patent for what has grown to be a multibillion-dollar market. The inner construction of an e-cigarette is quite simple and fairly standard and it is very obvious as to what our auto draw technology patent covers, and potential infringement is rather clear when you see it,” VPR Brands CEO Kevin Frija stated in the news release. “Our patent could be a huge windfall for the company either by enticing infringing companies to order product through VPR Brands or as an alternative pay royalty on infringing product. Infringement can be avoided by simply adding a button to the battery but there is a reason the preferred option by consumers and most manufactures to date to simulate real smoking is our buttonless auto draw technology which best mimics real smoking.”

To view the full press release, visit http://cnw.fm/Jb4YA

About VPR Brands, LP

VPR Brands is a technology company whose assets include issued U.S. and Chinese patents for atomization-related products, including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids, vaporizers and electronic cigarettes (also known as e-cigarettes) which are devices which deliver nicotine and or cannabis and cannabidiol (“CBD”) through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products. For more information, visit the company’s website at www.VPRBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://cnw.fm/VPRB

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW – New Jersey Could Have the Lowest Weed Taxes According to Voter Measure

If everything goes according to plan, New Jersey could be the state with the lowest tax rate for legal weed sales. Voters are expected to vote on a marijuana legalization measure that seeks to allow the state to subject a sales tax of 6.625% on legal weed sales.

All cities allowing the sale of legal weed would be authorized to impose a maximum of 2% transfer tax which would total up to 8.625%. This would still be the lowest tax imposed on legal marijuana sales in the U.S.

According to marijuana analysts, the low taxes would enable legal marijuana to compete with and eventually eradicate the illicit weed market. The period in which New Jersey will be able to start implementing the low rate tax is uncertain.

According to the president of the New Jersey Cannabusiness Association, Scott Rudder, voter approval for recreational weed in the 2020 elections could lead to additional details such as Excise taxes.

Rudder also said that the ballot question should be detailed so that the voters can make an informed decision.

He was of the view that the new regulations would not be implemented until the voters approve the measure, and the tax proposals for the marijuana industry may still be altered.

Rudder also said other states might legalize marijuana and the desire to have common taxes in the Northeast states where marijuana is legal may force New Jersey to abandon its measure in favor of a collective position agreed upon with neighboring states.

New Jersey would be the only state not imposing an additional tax, such as excise tax, because all the other states that have legalized recreational marijuana impose some excise tax on legal weed sales, which amounts to about 26% when you add both sales and excise tax.

Washington has the highest percentage of tax on legal weed sales, whose average is 43%, while Michigan customers pay the lowest, at 16%.

States where weed is legal allow their cities to impose their additional taxes besides the general sales taxes imposed by the state.

The executive director of the National Organization of Marijuana Laws, Erik Altieri, said that there is a possibility that New Jersey will impose some excise tax by the time the first ounce of legal cannabis is sold. Altieri further noted that the state law would continue to evolve once marijuana is legalized.

Legalization of weed has been a topic for debate in the Legislature for the last two years and the proposed pot taxes have gone through many changes. State Senator Nicholas Scutari introduced a bill in the state Assembly which suggested for an increasing marijuana tax which would begin at 7% and rise to 25% over the next few years. The last bill proposed a $42 flat-rate fee per ounce, which equates to a 12% tax rate. This would ensure a steady source of revenue, even if the market price for marijuana drops.

Scutari said that removing the additional taxes is a sure way of fighting the black market because people would be more inclined to buy the cheap, safe, and high-quality weed from a licensed dispensary instead of purchasing from an illegal dealer.

These proposals seem good on paper, but experts say industry actors like SinglePoint Inc. (OTCQB: SING) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) have learnt that nothing is clearcut in New jersey, so they will only wait to see the final law which is cleared for implementation.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Key Congressional Committee Passes Marijuana Legalization Bill

On Wednesday, a key Congressional committee passed legislation that would decriminalize and tax marijuana as well as expunging federal marijuana convictions. However, to become law, it has to be approved by the full House and the Republican-controlled Senate. The House Judiciary Committee passed the bill by a vote of 24 to 10.

The bill is known as the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2019 and was introduced by Rep. Jerrold Nadler (D-NY) and co-sponsored by more than 50 legislators. The legislation has the following provisions:

Remove weed from Schedule 1 of the Controlled Substance Act, which includes drugs such as heroin, fentanyl, and ecstasy.
Allow states to create their own marijuana policies, decriminalize low-level marijuana felonies, and seal the record for past federal convictions.
Create a Cannabis Justice Office that would impose a 5% tax on legal marijuana sales to fund job training, legal aid, and help people who are negatively affected by marijuana prohibition.

In a statement, Nadler said that the MORE Act has been long overdue. He further said that rather than handling marijuana as an issue of personal choice and public health, the government has been taking it as a criminal justice problem. Nadler asserted that it is unwise and unjust to federally arrest, prosecute and incarcerate people for using recreational or medical marijuana.

The Pew Research Center conducted a survey in November 2019 which revealed that more than two-thirds of American adults support the legalization of medical and adult-use marijuana. However, only 8% said that marijuana should remain illegal in all forms.

According to the National Conference of State Legislatures, currently, in the U.S., medical and recreational marijuana is legal in eleven states, including the District of Columbia, while medical marijuana is legal in 33 states.

Although the public is in favor of the bill, the majority of the Republicans are still on the fence about pursuing marijuana legalization.

On Wednesday, Colorado Republican and Committee member, Ken Buck said he is doubtful the Republicans will back this bill. He is almost sure that the Senate will not even consider it. Buck’s suggestion for the House is to deal with other measures that would get bipartisan support.

All 2020 presidential candidates, except the former Vice President Joe Biden, are in favor of marijuana legalization. Biden openly opposed marijuana legalization during the primary debates on Wednesday saying that more scientific research is needed to prove that it is not a “gateway drug.” Although the Centers for Disease Control agree with the need for further studies, the organization also noted that people who use weed do not proceed to use other hard drugs.

One can only imagine that marijuana companies like LiveWire Ergogenics Inc. (OTC: LVVV) and No Borders Inc. (OTC: NBDR) will only celebrate once the MORE Act is approved by Senate and signed into law by the President.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.